Despite the advanced medical technology we
have today, an effective treatment for Alzheimer's has not yet been
found that not only helps slow the progression of the disease but also
restores the brain to its previous state. However, a study conducted at
the University of California, Los Angeles, and published in August 2024
revealed a surprising discovery. Researchers managed to synthesize a
molecule called DDL-920 that restored the cognitive abilities of mice
with Alzheimer's, and this discovery might significantly change the way
the disease is treated. Not only could we slow its progression, but also
restore and repair the brain, erasing the harmful effects of
Alzheimer's disease.
How does one molecule help restore cognitive abilities?
Imagine your brain as a city, and the memory and thinking abilities are
powered by an electrical system that lights up this city. Alzheimer's
disease is a problem that disrupts the electrical flow of that system
and causes electrical shorts, leading to memory loss and confusion, just
like what would happen if some traffic lights and streetlights in the
city were to go out.
New molecule for Alzheimer's treatment: lights coming out of a brain.
Most existing treatments for Alzheimer's
are aimed at cleaning the "junk" that accumulates in the brain (plaque)
and causes these power outages, but the problem is that they don't
address the power outages themselves. In contrast, the newly discovered
molecule, named DDL-920, can actually do this, like an electrician
called to fix the electrical short, and thanks to it, the future of
Alzheimer's treatment looks much more promising.
"There is really nothing like this on the market or in the experimental
field, and no other treatment has shown the ability to do this," says
Dr. István Módy, a professor of neurology at the University of
California, Los Angeles, and the lead researcher. Indeed, even the
modern drugs recently approved by the U.S. Food and Drug Administration
(FDA), such as Lecanemab, which was approved for use in the U.S. in
2023, can only clean the plaque buildup in the brain but cannot repair
the damage it caused. "These drugs may leave a brain without plaque, but
all the pathological changes in the wiring mechanisms of nerve cells
remain damaged," says Dr. Módy, meaning they do not address the
cognitive problems that have already occurred.
The results in experiments look very
promising
The brain sends electrical signals at different rates to activate and
deactivate various functions within it, much like how traffic lights
work. Gamma wave oscillations are the ones that influence cognitive
processes and working memory – the type of memory that helps us remember
phone numbers, for example – and Alzheimer's patients who experience
symptoms such as memory impairment show a decrease in gamma wave
oscillations in their brains.
In other studies, attempts were made to
restore memory by increasing gamma wave oscillations with the help of
external aids, such as magnetic frequencies, but without success.
However, in the current study, there is a significant breakthrough.
Instead of trying to influence gamma wave oscillations using external
aids, the researchers decided to try to influence the brain from within –
with the help of molecules – and the molecule DDL-920 succeeded in the
task.
In lab experiments, mice with Alzheimer's symptoms and healthy mice were
tested, and they learned to navigate a maze with cues meant to lead
them to the exit hole. The mice suffering from Alzheimer's were given a
dose of the DDL-920 molecule twice a day for two weeks, and as a result,
they showed remarkable improvement in their ability to navigate the
maze and find the exit, functioning just as well as healthy mice in the
same maze.
Moreover, no negative side effects were observed from the treatment with
the molecule, so researchers speculate that treatment with it will be
safe for humans as well. However, more human trials are still needed to
confirm this theory. If the trials show success at the same level, the
molecule will allow effective treatments not only for Alzheimer's
patients but also for those with schizophrenia, depression, and people
on the autism spectrum.
Is this really a miracle cure for
Alzheimer's?
Dr. Módy claims that this mechanism has never been tested and studied
before, so it represents a new direction that researchers have not yet
tried, and it has a high chance of becoming the leading treatment for
Alzheimer's patients. As mentioned, many more trials are still needed on
the subject, but researchers are very optimistic. We hope to hear more
developments on this soon, and we would be happy to discover if, in the
near future, there will indeed be an available treatment that can
restore the brain function of Alzheimer's patients to its former state.
If so, we may be able to say goodbye to the damage caused by the disease
and hello to a new era where "Alzheimer's" is no longer a scary word,
but simply another disease that can be treated and its symptoms managed
with a simple and quick treatment.
This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.
https://gscrochetdesigns.blogspot.com. one can see my crochet creations
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
https://cancersupportindia.blogspot.com for infor on cancer and health related topics
https://GSiyers
home remedies.blogspot.com is the latest addition to my blogs. I'm
going to add posts there, do give me your valuable feed back on my
blogs. Thanks a lot, take care, be healthy and be happy.
Labels: Alzheimer's, amyloid plaques, autism, DDL-920 molecule, if success in humans- effective for depression, improves brain functions, Schizophrenia
0 Comments:
Post a Comment
<< Home